5-[[(1S)-1-[[(2R)-1-[[(2S)-5-(diaminomethylideneamino)-1-[[(2R)-1-[[(2S)-5-[formyl(hydroxy)amino]-1-[[(3S,6S,9S,12S)-9-[3-[formyl(hydroxy)amino]propyl]-3,6-bis[(1R)-1-hydroxyethyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclohexadec-12-yl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-8-hydroxy-9-oxo-1,2,3,4-tetrahydropyrimido[1,2-a]quinolin-5-yl]amino]-2,5-dioxopentanoic acid
| Internal ID | 822bc84d-e972-4314-90ee-511bbe77c3fb |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides |
| IUPAC Name | 5-[[(1S)-1-[[(2R)-1-[[(2S)-5-(diaminomethylideneamino)-1-[[(2R)-1-[[(2S)-5-[formyl(hydroxy)amino]-1-[[(3S,6S,9S,12S)-9-[3-[formyl(hydroxy)amino]propyl]-3,6-bis[(1R)-1-hydroxyethyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclohexadec-12-yl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-8-hydroxy-9-oxo-1,2,3,4-tetrahydropyrimido[1,2-a]quinolin-5-yl]amino]-2,5-dioxopentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C55H83N17O22/c1-27(77)43-52(89)59-15-4-3-8-30(46(83)64-33(11-7-19-71(94)26-76)49(86)68-44(28(2)78)53(90)69-43)63-47(84)32(10-6-18-70(93)25-75)66-51(88)36(24-74)67-48(85)31(9-5-16-60-55(56)57)65-50(87)35(23-73)61-41-14-17-58-45-34(62-42(82)13-12-38(79)54(91)92)20-29-21-39(80)40(81)22-37(29)72(41)45/h20-22,25-28,30-33,35-36,41,43-44,58,61,73-74,77-78,80,93-94H,3-19,23-24H2,1-2H3,(H,59,89)(H,62,82)(H,63,84)(H,64,83)(H,65,87)(H,66,88)(H,67,85)(H,68,86)(H,69,90)(H,91,92)(H4,56,57,60)/t27-,28-,30+,31+,32+,33+,35-,36-,41+,43+,44+/m1/s1 |
| InChI Key | RUIOLPSOXWTQMI-MYMJXMRCSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C55H83N17O22 |
| Molecular Weight | 1334.30 g/mol |
| Exact Mass | 1333.58985734 g/mol |
| Topological Polar Surface Area (TPSA) | 607.00 Ų |
| XlogP | -9.30 |
| Atomic LogP (AlogP) | -7.95 |
| H-Bond Acceptor | 25 |
| H-Bond Donor | 21 |
| Rotatable Bonds | 33 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7925 | 79.25% |
| Caco-2 | - | 0.8608 | 86.08% |
| Blood Brain Barrier | - | 0.6250 | 62.50% |
| Human oral bioavailability | - | 0.6429 | 64.29% |
| Subcellular localzation | Mitochondria | 0.4899 | 48.99% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8234 | 82.34% |
| OATP1B3 inhibitior | + | 0.9368 | 93.68% |
| MATE1 inhibitior | - | 0.7800 | 78.00% |
| OCT2 inhibitior | - | 0.6500 | 65.00% |
| BSEP inhibitior | + | 0.9147 | 91.47% |
| P-glycoprotein inhibitior | + | 0.7420 | 74.20% |
| P-glycoprotein substrate | + | 0.8683 | 86.83% |
| CYP3A4 substrate | + | 0.7486 | 74.86% |
| CYP2C9 substrate | - | 0.8038 | 80.38% |
| CYP2D6 substrate | - | 0.8496 | 84.96% |
| CYP3A4 inhibition | - | 0.5695 | 56.95% |
| CYP2C9 inhibition | - | 0.8266 | 82.66% |
| CYP2C19 inhibition | - | 0.8043 | 80.43% |
| CYP2D6 inhibition | - | 0.8742 | 87.42% |
| CYP1A2 inhibition | - | 0.7630 | 76.30% |
| CYP2C8 inhibition | + | 0.8236 | 82.36% |
| CYP inhibitory promiscuity | - | 0.9345 | 93.45% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.5213 | 52.13% |
| Eye corrosion | - | 0.9817 | 98.17% |
| Eye irritation | - | 0.8958 | 89.58% |
| Skin irritation | - | 0.7579 | 75.79% |
| Skin corrosion | - | 0.9217 | 92.17% |
| Ames mutagenesis | - | 0.5100 | 51.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6879 | 68.79% |
| Micronuclear | + | 0.9400 | 94.00% |
| Hepatotoxicity | - | 0.5725 | 57.25% |
| skin sensitisation | - | 0.8343 | 83.43% |
| Respiratory toxicity | + | 0.8111 | 81.11% |
| Reproductive toxicity | + | 0.8778 | 87.78% |
| Mitochondrial toxicity | + | 1.0000 | 100.00% |
| Nephrotoxicity | + | 0.6636 | 66.36% |
| Acute Oral Toxicity (c) | III | 0.5780 | 57.80% |
| Estrogen receptor binding | + | 0.5703 | 57.03% |
| Androgen receptor binding | + | 0.7219 | 72.19% |
| Thyroid receptor binding | + | 0.7383 | 73.83% |
| Glucocorticoid receptor binding | + | 0.7783 | 77.83% |
| Aromatase binding | + | 0.7660 | 76.60% |
| PPAR gamma | + | 0.7444 | 74.44% |
| Honey bee toxicity | - | 0.6632 | 66.32% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.6300 | 63.00% |
| Fish aquatic toxicity | - | 0.5000 | 50.00% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.84% | 98.95% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 99.73% | 94.45% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.01% | 96.09% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.66% | 94.45% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 98.56% | 93.10% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 97.97% | 98.05% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 97.11% | 90.71% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.47% | 97.09% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 95.65% | 99.17% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.63% | 91.11% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 95.09% | 95.38% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 94.19% | 92.88% |
| CHEMBL236 | P41143 | Delta opioid receptor | 92.46% | 99.35% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 92.45% | 95.50% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 92.42% | 96.11% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 92.35% | 89.00% |
| CHEMBL204 | P00734 | Thrombin | 92.28% | 96.01% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.12% | 95.56% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 90.67% | 96.90% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 90.31% | 96.47% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 89.65% | 96.00% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 89.25% | 98.33% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 89.03% | 91.19% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 88.88% | 97.14% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 88.66% | 98.24% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.65% | 93.00% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 88.33% | 94.33% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 88.33% | 91.03% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 88.04% | 95.89% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 88.02% | 97.64% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 87.10% | 89.63% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 86.85% | 93.03% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 86.34% | 88.42% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 86.26% | 83.82% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 85.71% | 93.56% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 85.62% | 97.33% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 85.02% | 100.00% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 85.01% | 95.00% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 84.91% | 83.10% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 84.39% | 99.15% |
| CHEMBL5284 | Q96RR4 | CaM-kinase kinase beta | 84.05% | 89.23% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 83.48% | 95.89% |
| CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 | 83.17% | 97.03% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 82.67% | 94.66% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 82.67% | 100.00% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 82.31% | 97.23% |
| CHEMBL2535 | P11166 | Glucose transporter | 82.17% | 98.75% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 81.92% | 95.71% |
| CHEMBL4235 | P28845 | 11-beta-hydroxysteroid dehydrogenase 1 | 81.71% | 97.98% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 81.62% | 80.71% |
| CHEMBL5028 | O14672 | ADAM10 | 81.60% | 97.50% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 81.52% | 99.23% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 81.44% | 89.50% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 80.11% | 95.20% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 80.09% | 96.25% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 102446707 |
| LOTUS | LTS0002941 |
| wikiData | Q105245638 |